SCHEMBL7255605

SCHEMBL7255605

CCCc1cc(=O)oc2ccccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B3 P37058 3/20 0.65
KDM4E B2RXH2 4/20 0.56
ALDH1A1 P00352 6/20 0.56
HPGD P15428 3/20 0.56
GAA P10253 2/20 0.56
HSD17B10 Q99714 2/20 0.56
TSHR P16473 2/20 0.55
MAPT P10636 2/20 0.55
ALDH1A2 O94788 1/20 0.55
ALDH2 P05091 1/20 0.55
ALDH1B1 P30837 1/20 0.55
ALDH1A3 P47895 1/20 0.55
CYP1A2 P05177 1/20 0.54
CYP3A4 P08684 1/20 0.54
CYP2C9 P11712 1/20 0.54
CYP2C19 P33261 1/20 0.54
ERAP1 Q9NZ08 1/20 0.54
NQO1 P15559 1/20 0.53
POLB P06746 2/20 0.52
CA12 O43570 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1415057 0.89 ALDH1A1 (0.61) HSD17B3KDM4EALDH1A1HPGDGAA
SCHEMBL8372531 0.87 HSD17B3 (0.62) HSD17B3KDM4EALDH1A1HPGDGAA
Umbelliferone SCHEMBL3762137 0.84 HSD17B3 (0.70) HSD17B3KDM4EALDH1A1HPGDGAA
SCHEMBL4209990 0.83 SLC18A1 (0.60) HSD17B3ALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL300152 0.83 NQO1 (0.53) HSD17B3KDM4EALDH1A1HPGDGAA
Diethylamine SCHEMBL28338576 0.81 RECQL (0.51) HSD17B3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5459900 0.80 CA12 (0.61) HSD17B3ALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL18138409 0.80 NQO1 (0.58) HSD17B3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL30486066 0.80 CA12 (0.61) HSD17B3ALDH1A1HPGDHSD17B10CYP3A4
SCHEMBL24523102 0.80 NQO1 (0.50) HSD17B3KDM4EALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030176494-A1 Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections ADVANCED LIFE SCIENCES, INC. 2003-09-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030176494-A1 Novel coumarin and chromene compounds and methods of preparation and use thereof for treating or preventing viral infections HAVCR2, PROC, CTRC HSD17B3 633/4885KDM4E 3488/4885ALDH1A1 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.